Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Andreea Adelina Artenie"'
Autor:
Chiedozie Arum, MSc, Hannah Fraser, PhD, Andreea Adelina Artenie, PhD, Sandra Bivegete, MSc, Adam Trickey, PhD, Michel Alary, ProfPhD, Jacquie Astemborski, MHS, Jennifer Iversen, PhD, Aaron G Lim, DPhil, Louis MacGregor, PhD, Meghan Morris, PhD, Jason J Ong, PhD, Lucy Platt, ProfPhD, Rachel Sack-Davis, PhD, Daniela K van Santen, PhD, Sunil S Solomon, MBSS, Vana Sypsa, PhD, Jorge Valencia, PhD, Wijnand Van Den Boom, PhD, Josephine G Walker, PhD, Zoe Ward, PhD, Jack Stone, PhD, Peter Vickerman, ProfDPhil, Peter Cherutich, Kora Debeck, Paul Dietze, Kostyantyn Dumchev, Kanna Hayashi, Margaret Hellard, Matthew Hickman, Vivian Hope, Ali Judd, Martin Kåberg, Ann E. Kurth, Pascale Leclerc, Lisa Maher, Shruti H. Mehta, Kimberly A Page, Maria Prins, Catherine S. Todd, Steffanie A. Strathdee
Publikováno v:
The Lancet Public Health, Vol 6, Iss 5, Pp e309-e323 (2021)
Summary: Background: People who inject drugs (PWID) are at increased risk for HIV and hepatitis C virus (HCV) infection and also have high levels of homelessness and unstable housing. We assessed whether homelessness or unstable housing is associated
Externí odkaz:
https://doaj.org/article/2c4f83ed900e4b0889089f4803177645
Publikováno v:
The Lancet Gastroenterology & Hepatology. 8:253-270
Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs
Autor:
Nanor Minoyan, Didier Jutras-Aswad, Geng Zang, Andreea Adelina Artenie, Julie Bruneau, Marie-Ève Turcotte
Publikováno v:
American Journal of Preventive Medicine. 58:845-853
Introduction Needle and syringe programs and opioid agonist therapy are essential for harm reduction among people who inject drugs. Few studies assess their combined potential in preventing hepatitis C virus infection. No studies have assessed whethe
Autor:
Alexandra B. Collins, Matthew Bonn, Lise Lafferty, Jaimie P. Meyer, Evan B Cunningham, Andreea Adelina Artenie, Behzad Hajarizadeh, Jason Grebely, Carla Treloar, Joshua A. Barocas, Alison D. Marshall, Rachel Sutherland, Oluwaseun Falade-Nwulia, Javier A. Cepeda, Jeffrey V. Lazarus
Publikováno v:
The International journal on drug policy. 96
Publikováno v:
International Journal of Drug Policy. 72:11-23
As direct-acting antiviral (DAA) therapy costs fall and eligibility criteria are relaxed, people who inject drugs (PWID) will increasingly become eligible for HCV treatment. Yet eligibility does not necessarily equate to access. Amidst efforts to exp
Autor:
Zoë R Greenwald, Evan B Cunningham, Chisom Ifeoma Adaeze Okwor, Michael A Palmer, Adam Palayew, Mohamed N Abdelnabi, Ching-Hsuan Liu, Andrew B. Mendlowitz, Yasmin Saeed, Hannah L Wallace, Nanor Minoyan, Catia T. Perciani, Dahn Jeong, Simmone D'souza, Gayatri Marathe, Marylin Rheault, Rasika D Kunden, Andreea Adelina Artenie, Gillian Kolla, Sabrina Mazouz, Charlotte Lanièce Delaunay
Publikováno v:
Can Liver J
Autor:
Emmanuel Fortier, Andreea Adelina Artenie, Jason Grebely, Stine Bordier Høj, Didier Jutras-Aswad, Marie-Pierre Sylvestre, Julie Bruneau, Nanor Minoyan
Publikováno v:
International Journal of Drug Policy. 96:103439
Background Frequent injecting increases hepatitis C (HCV) acquisition risk among people who inject drugs (PWID). However, few studies have examined how temporal fluctuations in injecting frequency may effect HCV infection risk. Thus, this study exami
Autor:
Lise Gauvin, Marie-Pierre Sylvestre, Julie Bruneau, Andreea Adelina Artenie, Didier Jutras-Aswad, Emmanuel Fortier, Stine Bordier Høj, Nanor Minoyan
Publikováno v:
International Journal of Drug Policy. 94:103205
Background Little is known about how socioeconomic circumstances relate to injection frequencies among people who inject drugs (PWID) with diverse trajectories of injection. We aimed to characterize trajectories of injection drug use in a community-b
Autor:
Élise Roy, Emmanuel Fortier, Svetlana Puzhko, Didier Jutras-Aswad, Geng Zang, Andreea Adelina Artenie, Julie Bruneau
Publikováno v:
International Journal of Drug Policy. 47:61-68
Background Prescription opioid (PO) injection and poly-drug use have been associated with hepatitis C virus (HCV) infection among people who inject drugs (PWID). Poly-drug use is often a barrier to key HCV preventive programmes including opioid agoni
Autor:
Julie Bruneau, Andreea Adelina Artenie
Publikováno v:
CMAJ
We appreciate the comments by Trujols and colleagues[1][1] on our CMAJ article.[2][2] We wish to highlight that the thresholds used to dichotomize the prescribed dosage for opioid agonist treatment in our study were informed by 3 national clinical gu